Literature DB >> 8364040

Perturbation of the carboxy terminus of HIV-1 Rev affects multimerization on the Rev responsive element.

T J Daly1, P Rennert, P Lynch, J K Barry, M Dundas, J R Rusche, R C Doten, M Auer, G K Farrington.   

Abstract

Perturbations within the transactivation and carboxy-terminal domains of HIV-1 Rev were examined for effects on Rev responsive element (RRE) binding activities in vitro and biological activity in vivo. Binding affinities, specificities, and multimerization of the transactivation mutants M10 and Rev/Rex M10-16 on the RRE were equivalent to wild-type Rev. Substitution of the Rex transactivation domain within Rev resulted in the incorporation of an internal methionine residue which, when cleaved with CNBr and subsequently purified, produced a protein species (CNBr-Rev) unable to fully multimerize on the RRE. Instead, two discrete protein-dependent species were generated in the gel shift assay. Furthermore, CNBr-Rev was observed to bind to the RRE with high specificity and an equilibrium binding constant of 6 x 10(-10) M. A C-terminal Rev deletion mutant (Rev M9 delta 14) lacking amino acids 68-112 displayed identical RRE binding characteristics to the CNBr-Rev protein. This protein, which lacks both the activation and the C-terminal domains, was biologically inactive but maintained the ability to discriminate the RRE from nonspecific RNA. Deletion of amino acids 92-112 resulted in a Rev mutant (Rev M11 delta 14) which bound to the RRE with wild-type affinity and high specificity. This purified mutant was observed to be aberrant in multimerization activity on the RRE with reduced multimerization apparent in the gel shift assay. However, Rev M11 delta 14 possessed biological activity equivalent to wild-type Rev in a cell-based p24 ELISA assay. These results suggest that polymerization on the RRE is dispensable for Rev activity and that two monomeric Rev proteins bound to the RRE are sufficient for biological activity. Furthermore, in vivo experiments using the Rev/Rex chimeric mutant and the M10 transdominant mutant as well as in vitro dissociation rate studies with Rev M11 delta 14 and Rev M9 delta 14 suggest that the M9 through M11 domain of the protein may be involved in RRE-dependent specific Rev dimerization.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8364040     DOI: 10.1021/bi00085a028

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

1.  Single-nucleotide changes in the HIV Rev-response element mediate resistance to compounds that inhibit Rev function.

Authors:  Deidra Shuck-Lee; Hua Chang; Emily A Sloan; Marie-Louise Hammarskjold; David Rekosh
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

2.  Scanning mutagenesis of the arginine-rich region of the human immunodeficiency virus type 1 Rev trans activator.

Authors:  M Hammerschmid; D Palmeri; M Ruhl; H Jaksche; I Weichselbraun; E Böhnlein; M H Malim; J Hauber
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

3.  Nuclear export of the human immunodeficiency virus type 1 nucleocytoplasmic shuttle protein Rev is mediated by its activation domain and is blocked by transdominant negative mutants.

Authors:  A M Szilvay; K A Brokstad; R Kopperud; G Haukenes; K H Kalland
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

4.  RNA aptamers selected to bind human immunodeficiency virus type 1 Rev in vitro are Rev responsive in vivo.

Authors:  T L Symensma; L Giver; M Zapp; G B Takle; A D Ellington
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

5.  Genetic diversity of simian immunodeficiency viruses from West African green monkeys: evidence of multiple genotypes within populations from the same geographical locale.

Authors:  F Bibollet-Ruche; C Brengues; A Galat-Luong; G Galat; X Pourrut; N Vidal; F Veas; J P Durand; G Cuny
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

6.  Evolution of the HIV-1 Rev Response Element during Natural Infection Reveals Nucleotide Changes That Correlate with Altered Structure and Increased Activity over Time.

Authors:  Chringma Sherpa; Patrick E H Jackson; Laurie R Gray; Kathryn Anastos; Stuart F J Le Grice; Marie-Louise Hammarskjold; David Rekosh
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

7.  Characterization of human immunodeficiency virus-1 (HIV-1) rev by (time-resolved) fluorescence spectroscopy.

Authors:  A J Kungl; C Seidel; A Schilk; T J Daly; H F Kauffmann; M Auer
Journal:  J Fluoresc       Date:  1994-12       Impact factor: 2.217

8.  Formation of trans-activation competent HIV-1 Rev:RRE complexes requires the recruitment of multiple protein activation domains.

Authors:  Dirk Hoffmann; Doreen Schwarck; Carina Banning; Matthias Brenner; Lakshmikanth Mariyanna; Marcel Krepstakies; Michael Schindler; David P Millar; Joachim Hauber
Journal:  PLoS One       Date:  2012-06-04       Impact factor: 3.240

9.  Cofactor requirements for nuclear export of Rev response element (RRE)- and constitutive transport element (CTE)-containing retroviral RNAs. An unexpected role for actin.

Authors:  W Hofmann; B Reichart; A Ewald; E Müller; I Schmitt; R H Stauber; F Lottspeich; B M Jockusch; U Scheer; J Hauber; M C Dabauvalle
Journal:  J Cell Biol       Date:  2001-03-05       Impact factor: 10.539

10.  Evidence that HIV-1 Rev directly promotes the nuclear export of unspliced RNA.

Authors:  U Fischer; S Meyer; M Teufel; C Heckel; R Lührmann; G Rautmann
Journal:  EMBO J       Date:  1994-09-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.